Cargando…
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
Increasingly, antibodies are being used to treat and prevent viral infections. In the context of HIV, efficacy is primarily attributed to dose-dependent neutralization potency and to a lesser extent Fc-mediated effector functions. It remains unclear whether augmenting effector functions of broadly n...
Autores principales: | Spencer, David A., Goldberg, Benjamin S., Pandey, Shilpi, Ordonez, Tracy, Dufloo, Jérémy, Barnette, Philip, Sutton, William F., Henderson, Heidi, Agnor, Rebecca, Gao, Lina, Bruel, Timothée, Schwartz, Olivier, Haigwood, Nancy L., Ackerman, Margaret E., Hessell, Ann J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814042/ https://www.ncbi.nlm.nih.gov/pubmed/35115533 http://dx.doi.org/10.1038/s41467-022-28250-7 |
Ejemplares similares
-
Complement contributes to antibody-mediated protection against repeated SHIV challenge
por: Goldberg, Benjamin S., et al.
Publicado: (2023) -
Sex and species associated differences in Complement-mediated immunity in Humans and Rhesus macaques
por: Kelkar, Natasha S., et al.
Publicado: (2023) -
Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity
por: Goldberg, Benjamin S., et al.
Publicado: (2021) -
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2018) -
Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis
por: Bushey, Ryan T., et al.
Publicado: (2021)